Monotherapy with either Dutasteride or Doxazosin after 2 years of combination therapy in men with benign prostatic hyperplasia: effects on lower urinary tract symptoms.
Phase of Trial: Phase IV
Latest Information Update: 11 Dec 2013
At a glance
- Drugs Doxazosin (Primary) ; Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- 09 Aug 2011 New trial record